scholarly journals The role of N -glycans of HIV-1 gp41 in virus infectivity and susceptibility to the suppressive effects of carbohydrate-binding agents

Retrovirology ◽  
2014 ◽  
Vol 11 (1) ◽  
pp. 107 ◽  
Author(s):  
Leen Mathys ◽  
Jan Balzarini
2013 ◽  
Vol 68 (9) ◽  
pp. 2026-2037 ◽  
Author(s):  
M. I. Petrova ◽  
L. Mathys ◽  
S. Lebeer ◽  
S. Noppen ◽  
E. J. M. Van Damme ◽  
...  

2009 ◽  
Vol 83 (1) ◽  
pp. 61-70 ◽  
Author(s):  
Joeri Auwerx ◽  
Katrien O. François ◽  
Els Vanstreels ◽  
Kristel Van Laethem ◽  
Dirk Daelemans ◽  
...  

2009 ◽  
Vol 82 (2) ◽  
pp. A22
Author(s):  
Marijke Alen ◽  
Suzanne J.F. Kaptein ◽  
Tine De Burghgraeve ◽  
Johan Neyts ◽  
Jan Balzarini ◽  
...  

2015 ◽  
Vol 96 (12) ◽  
pp. 3660-3666 ◽  
Author(s):  
Bodan Hu ◽  
Tao Du ◽  
Chang Li ◽  
Sukun Luo ◽  
Yalan Liu ◽  
...  

Human immunodeficiency virus type 1 (HIV-1) transmission often results from infection by a single transmitted/founder (T/F) virus. Here, we investigated the sensitivity of T/F HIV-1 envelope glycoproteins (Envs) to microbicide candidate carbohydrate-binding agents (CBAs) griffithsin (GRFT), cyanovirin-N (CV-N) and Galanthus nivalis agglutinin (GNA), showing that T/F Envs demonstrated different sensitivity to CBAs, with IC50 values ranging from 0.006 ± 0.0003 to >10 nM for GRFT, from 0.6 ± 0.2 to 28.9 ± 2.9 nM for CV-N and from 1.3 ± 0.2 to >500 nM for GNA. We further revealed that deglycosylation at position 295 or 448 decreased the sensitivity of T/F Env to GRFT, and at 339 to both CV-N and GNA. Mutation of all the three glcyans rendered a CBA-sensitive T/F Env largely resistant to GRFT, indicating that the sensitivity of T/F Env to GRFT is mainly determined by glycans at 295, 339 and 448. Our study identified specific T/F Env residues associated with CBA sensitivity.


Pathogens ◽  
2020 ◽  
Vol 9 (6) ◽  
pp. 425
Author(s):  
Chih-Yen Lin ◽  
Wen-Hung Wang ◽  
Szu-Wei Huang ◽  
Chun-Sheng Yeh ◽  
Ruei-Yu Yuan ◽  
...  

HIV-1 CRF07_BC is a B’ and C subtype recombinant emerging virus and many of its viral characteristics remain unclear. Galectin-3 (Gal3) is a β-galactose binding lectin that has been reported as a pattern recognition receptor (PRR) and is known to mediate adhesion between cells and microbes. This study aims to examine the viral characteristics of HIV-1 CRF07_BC virus and the role of extracellular galectin-3 in HIV-1 CRF07_BC infection. A total of 28 HIV-1+ injecting drug users (IDUs) were recruited and 24 (85.7%) were identified as HIV-1 CRF07_BC. Results indicate that significant higher serum galectin-3 was measured in CRF07_BC infected patients and CRF07_BC infection triggered significant galectin-3 expression (p < 0.01). Viral characteristics demonstrate that CRF07_BC virions display a higher level of envelope gp120 spikes. The virus infectivity assay demonstrated that co-treatment with galectin-3 significantly promoted CRF07_BC attachment and internalization (p < 0.01). A co-immunoprecipitation assay showed that pulldown galectin-3 co-precipitated both CD4 and gp120 proteins. Results from an enzyme-linked immunosorbent assay (ELISA) indicate that the galectin-3 promoting effect occurs through enhancement of the interaction between gp120 and CD4. This study suggests that CRF07_BC was predominant in HIV-1+ IDUs and CRF07_BC utilized extracellular galectin-3 to enhance its infectivity via stabilization of the gp120-CD4 interaction.


Parasitology ◽  
2019 ◽  
Vol 146 (14) ◽  
pp. 1743-1754
Author(s):  
Maria Valente ◽  
Víctor M. Castillo-Acosta ◽  
Antonio E. Vidal ◽  
Dolores González-Pacanowska

AbstractKinetoplastid parasites are responsible for serious diseases in humans and livestock such as Chagas disease and sleeping sickness (caused by Trypanosoma cruzi and Trypanosoma brucei, respectively), and the different forms of cutaneous, mucocutaneous and visceral leishmaniasis (produced by Leishmania spp). The limited number of antiparasitic drugs available together with the emergence of resistance underscores the need for new therapeutic agents with novel mechanisms of action. The use of agents binding to surface glycans has been recently suggested as a new approach to antitrypanosomal design and a series of peptidic and non-peptidic carbohydrate-binding agents have been identified as antiparasitics showing efficacy in animal models of sleeping sickness. Here we provide an overview of the nature of surface glycans in three kinetoplastid parasites, T. cruzi, T. brucei and Leishmania. Their role in virulence and host cell invasion is highlighted with the aim of identifying specific glycan–lectin interactions and carbohydrate functions that may be the target of novel carbohydrate-binding agents with therapeutic applications.


PLoS ONE ◽  
2013 ◽  
Vol 8 (5) ◽  
pp. e64132 ◽  
Author(s):  
Bart Hoorelbeke ◽  
Jie Xue ◽  
Patricia J. LiWang ◽  
Jan Balzarini

Sign in / Sign up

Export Citation Format

Share Document